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Repeat Length and RNA Expression Level Are Not
Primary Determinants in CUG Expansion Toxicity in
Drosophila Models
Gwenn Le Me´e, Nader Ezzeddine¤, Miche`le Capri, Ounissa Aı¨t-Ahmed*
Institut de Ge´ne´tique Humaine, Unite´ Propre de Recherche 1142, Centre National de la Recherche Scientifique, Montpellier, France
Evidence for an RNA gain-of-function toxicity has now been provided for an increasing number of human pathologies.
Myotonic dystrophies (DM) belong to a class of RNA-dominant diseases that result from RNA repeat expansion toxicity.
Specifically, DM of type 1 (DM1), is caused by an expansion of CUG repeats in the 39UTR of the DMPK protein kinase mRNA,
while DM of type 2 (DM2) is linked to an expansion of CCUG repeats in an intron of the ZNF9 transcript (ZNF9 encodes a zinc
finger protein). In both pathologies the mutant RNA forms nuclear foci. The mechanisms that underlie the RNA pathogenicity
seem to be rather complex and not yet completely understood. Here, we describe Drosophila models that might help
unravelling the molecular mechanisms of DM1-associated CUG expansion toxicity. We generated transgenic flies that express
inducible repeats of different type (CUG or CAG) and length (16, 240, 480 repeats) and then analyzed transgene localization,
RNA expression and toxicity as assessed by induced lethality and eye neurodegeneration. The only line that expressed a toxic
RNA has a (CTG)240 insertion. Moreover our analysis shows that its level of expression cannot account for its toxicity. In this
line, (CTG)240.4, the expansion inserted in the first intron of CG9650, a zinc finger protein encoding gene. Interestingly, CG9650
and (CUG)240.4 expansion RNAs were found in the same nuclear foci. In conclusion, we suggest that the insertion context is the
primary determinant for expansion toxicity in Drosophila models. This finding should contribute to the still open debate on the
role of the expansions per se in Drosophila and in human pathogenesis of RNA-dominant diseases.
Citation: Le Me´e G, Ezzeddine N, Capri M, Aı¨t-Ahmed O (2008) Repeat Length and RNA Expression Level Are Not Primary Determinants in CUG
Expansion Toxicity in Drosophila Models. PLoS ONE 3(1): e1466. doi:10.1371/journal.pone.0001466
INTRODUCTION
Myotonic dystrophy type 1 (DM1), also called Steinert myotonic
dystrophy is a multi-systemic pathology originally described as a
neuromuscular disorder [1]. It is an autosomal dominant disease
genetically linked to a CTG trinucleotide expansion localized in
the 39UTR of DMPK [2–4]. DMPK encodes a serine-threonine
protein kinase which phosphorylates various proteins including
CUG-BP1, a CELF protein (CUG-BP/ETR3-like factor) whose
dysfunction is involved in DM1 pathogenesis [5].
Essentially three models have been proposed to account for the
physiopathology, the genetic inheritance and the molecular
characteristics of DM1: 1) haploinsufficiency of DMPK; 2)
transcription repression at DMPK adjacent loci; 3) toxicity of the
CUG expansion containing RNA. Given the complexity of the
pathology, it is possible that all these mechanisms contribute to the
phenotype ([6,7] and references therein). Arguments in favour of the
RNA gain-of-function model were provided by the discovery of
another myotonic dystrophy called DM2 (for type 2). DM2 is caused
by a CCTG repeat expansion within the first intron of ZN9, a gene
that encodes a zinc finger protein. This gene is not related to any of
the genes that map in the vicinity of the DMPK locus [8,9]. In both
DM1 and DM2, the common molecular features are the RNA foci
formed in the nuclei of cells from patients. The toxicity was therefore
attributed to the expansion and would result from an entrapment in
the RNA foci of nuclear factors, such as those involved in the splicing
of specific mRNAs ([7] and references therein). Thus, the deleterious
dominant effect of the CUG expanded RNA could be mediated by
CUG binding proteins [10]. Indeed, defective splicing of RNA
targets of the CUG binding proteins has been well documented and
could explain some aspects of DM1 physiopathology [7]. CUG-BP1
was one of the first CUG binding proteins to be associated with DM1
[11], but although its level increases in DM1, it has not been detected
in the nuclear foci [12,13]. On the other hand, Muscleblind-like
protein family members, such as MBNL1 in humans, bind to CUG
repeats and are associated with the nuclear foci [14]. However,
recent work clearly establishes that MBNL1 presence in RNA foci is
not sufficient to account for the pathological effect of the expansion
as MBLN1 was also found to be associated with non pathological
nuclear foci [15]. The identification of another CUG expanded
RNA binding factor, namely hnRNP H is more promising as in
hnRNP H depeleted cells, CUG expansions do not form nuclear
aggregates [16].
The finding that hnRNP H binds only to a specific sequence/
structure (CUG repeat and splicing branch point distal to the repeat),
demonstrates that RNA expansions acquire new properties which
are dependent on the sequences in which they reside. Indeed, the
basic view that nuclear aggregates formed by CUG expansions are
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intrinsically toxic and/or that toxicity severity is determined only by
the size of the repeats and their concentration have been already
challenged by various studies [6,17–19]. Therefore, the mechanisms
that underlie the RNA gain-of-function toxicity remain elusive and
deserve to be further investigated.
To this aim, we generated fly transgenic lines to try to
understand the role of repeat type, repeat length, RNA expression
levels and RNA insertion context in the formation of nuclear foci
and expansion toxicity. We show that CUG expansions do not
have a toxic effect in most of the transgenic lines with the
exception of the (CTG)240.4 line that develops a deleterious
phenotype upon ubiquitous or neuronal induction. Furthermore,
all the (CUG)240 and (CUG)480 RNAs, but not the (CUG)16 RNA,
form nuclear foci regardless of whether they have a toxic effect or
not. We also demonstrate that in the (CTG)240.4 line, the
expansion is inserted in an endogenous gene, CG9650, that
encodes a zinc finger (ZNF) protein [20,21]. CG9650 RNA co-
localizes with the CUG expansion in the nuclear foci. We thus
suggest that the toxicity of this (CUG)240.4 expansion correlates
with the fusion transcript that it forms with CG9650 RNA.
RESULTS
Construct cloning and transgene stability
assessment in transgenic flies
Our aim was to generate transgenic flies using the UAS/GAL4
system [22] to address the issue of the RNA gain-of-function toxicity.
Specifically, we wanted to identify which repeat length (16, 240 or
480 repeats) and which type of repeat (CUG or CAG) are needed for
RNA nuclear retention and toxicity. The 240 and 480 repeats used
in these experiments were the interrupted repeats that have been
previously used in cell models [5,23]. They were cloned, without any
coding sequence, in the Drosophila UASp vector. The (CTG)16
constructs were cloned in the SV40 39UTR downstream the LacZ
ORF. Five (CTG)240, three (CTG)480, one (CAG)240, two (CAG)480
and three (CTG)16 transgenic lines were generated.
First, we assessed the genomic stability of the expansions in
subsequent generations, by determining their size by PCR
amplification with primers complementary to sequences that were
at each side of the repeats (Figure 1A). After more than 100
generations the expansion size remained unchanged indicating
that the large expansions were stable in Drosophila (figure 1B). This
is in striking contrast with their instability in bacteria, as observed
during the cloning process.
CUG repeat expansions expressed in various tissues
accumulate in nuclear foci
Tissue-specific induction of the repeat expansions was achieved by
crossing UAS-(CTG)n lines with Gal4 driver flies [22]:MS1096-Gal4
flies for expression in the salivary glands of the third instar larvae
[24], 24B-Gal4 flies for induction in the larval muscle cells [22] and
COG-Gal4 flies to induce ovary expression [25]. We tested all the
(CTG)n transgenic lines for (CUG)n expression using RNA
fluorescence hybridization (RNA-FISH) with a CAG-FITC probe
(Figure 2). In salivary glands, all the induced (CUG)240 and (CUG)480
RNAs formed nuclear foci that were localized in a small area of the
nucleus (Figure 2A). In contrast, in the nuclei of larval muscle cells
(Figure 2B) and ovarian nurse cells (Figure 2C), we observed the
presence of speckles of variable size, shape and number. The absence
of hybridization in non induced lines is an indication that the signal
detected by the FISH probe was not due to DNA staining. The
(CUG)16 transgenic RNAs did not form nuclear foci (Figure 2A).
Using a CTG-FITC probe, we failed to detect nuclear foci in the
(CAG)240 and (CAG)480 lines (data not shown).
To unambiguously assign to RNA the localized signal observed
in the salivary glands nuclei, we treated the specimens with
ribonuclease before the RNA-FISH procedure. After ribonuclease
treatment, we could not detect the nuclear foci any more, whereas
the DAPI signal was not affected (Figure 3).
Therefore, the nuclear foci were due specifically to the induced
(CUG)240 and (CUG)480 expanded RNAs.
Figure 1. Transgenic constructs and expansion size verification. A. Organization of the (CTG)n containing transgenes. Grey boxes: UASp plasmid
sequences inserted in genomic DNA. White boxes: CTG repeat tracts (CTG) n = 16, 240 or 480 or CAG repeat tracts (CAG) n = 240 or 480. Black boxes: non
repeated flanking sequences. For the small repeat tract (n = 16) the LacZ ORF is shown as a hatched box. The two primers (1 and 2) used to amplify
the transgene were complementary to vector sequences and are common to all constructs. PCR amplifications required specific conditions because
of the difficulty to amplify the repeat tracts especially when n = 480 (see Material and Methods). B. Gel electrophoresis analysis of PCR fragments of
the transgenic flies genomic DNA amplified using primers 1 and 2. LacZ-CTG n = 16 (lanes 1–3), CTG n = 240 (lanes 4–8), CTG n = 480 (lanes 10–11), CAG
n = 240 (lanes 12) or CAG n = 480 (lanes 13–14), wild type control DNA (WT) (lane 15). The discrepancy in the size of (CTG)480 and (CAG)480 reflects a
difference in the black boxed flanking sequences, see Material and Methods. (*) partial loss of the CTG n = 480 tract (line 9) during the cloning process
in bacteria. In Drosophila they have been stable through hundreds generations. Lane 16: 1kb DNA ladder (Promega).
doi:10.1371/journal.pone.0001466.g001
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Figure 2. Whole mount RNA-FISH analysis using a CAG-FITC probe. UAS-(CTG)n flies were crossed with Gal4 driver flies and raised at 25uC. For
transgene induction, the temperature was raised to 29uC for 12 h before dissection. A. Expression pattern of (CUG)n containing RNAs induced in
salivary glands by the MS1096-Gal4 driver [24]. Upon induction, (CUG)n containing RNAs formed a single nuclear focus in salivary glands of all the
transgenic lines where n = 240 or 480. The nuclear signal was absent in lines with n = 16 repeats and in non induced flies. B. Expression pattern of
(CUG)n containing RNAs induced in muscles of third instar larvae with the 24B-Gal4 driver [22]. (CUG)n RNAs formed several nuclear foci in muscles of
all the transgenic lines examined where n = 240 or 480. No foci were detected when transgenes were not induced. C. Expression pattern of (CUG)n
containing RNAs induced in ovaries with the COG-Gal4 driver [25]. (CUG)n containing RNA formed multiple foci in all the transgenic lines where
n = 240 or 480. No foci were detected in non induced flies (data not shown). DNA was stained with DAPI.
doi:10.1371/journal.pone.0001466.g002
Toxicity of CUG Expansions
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A single transgenic line, (CTG)240.4, expresses a toxic
(CUG)240.4 RNA
We used two tests to evaluate the toxicity of the RNA expansion
repeats: lethality and eye neurodegeneration both induced by
different Gal4 driver lines (Figure 4). The Actin-Gal4 constitutive
driver, the Elav-Gal4 and Da-Gal4 pan-neural drivers [26,27] and
the BG380-Gal4 motoneuron driver [28] were used to assess
lethality. To our surprise, although all (CTG)240 and (CTG)480
lines produced nuclear foci, only the (CTG)240.4 had problems of
viability. Indeed, upon ubiquitous and pan-neural induction the
viability of this transgenic line was reduced to 0% and to 21%
when the motoneuron-specific driver BG380-Gal4 was used
(Figure 4A). BG380-Gal4 is active at larval stages, therefore, it is
possible that defects resulting from the RNA toxicity hinder larval
movement and feeding [28]. Similarly, only the (CTG)240.4 line
was sensitive to induction by the GMRnina-Gal4 driver which is
specific for photoreceptor neurons [29,30]. Eye examination using
scanning electron microscopy (Figure 4B) revealed a massive
disorganization of ommatidia and mechanosensory bristles, an
evidence of neurodegeneration (Figure 4B).
Figure 3. Nuclear foci formed in induced transgenic lines are RNase sensitive. The induction was performed in salivary glands as in Figure 2A.
Nuclear foci formed upon driver induction were not detectable when the salivary glands were submitted to ribonuclease treatment before the FISH
procedure.
doi:10.1371/journal.pone.0001466.g003
Figure 4. CUG expansion toxicity in Drosophila upon induction with various drivers. Transgene expression was achieved by raising flies that bear
both UAS-(CTG)n and Gal4 drivers at 25uC. A. Bar graph showing fly viability ratio in induced and non-induced conditions. Transgene expression was
driven by the ubiquitous Actin-Gal4 driver P{Act5C-GAL4}25FO1. the BL#4414 pan-neuronal elav-Gal4 driver [26], the daughterless-Gal4 (da-Gal4)
driver [27] and the motoneuronal BG380-Gal4 driver [28]. Viability was affected only in one of the (CUG)240 RNA expressing lines, the (CUG)240.4 (black
boxes). No survival was observed upon ubiquitous and pan-neuronal expression and 21% viability was observed upon motoneuron induction for the
(CUG)240.4 line. None of the other lines was affected (white boxes). B. Scanning Electron Microscopy of mutant and wild type eyes. Eye
neurodegeneration upon GMRnina-Gal4 driver induction [30] was observed only in the (CUG)240.4 line whereas all the other expansion lines had wild
type eyes.
doi:10.1371/journal.pone.0001466.g004
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Insertion instability/size, or a discrepancy in RNA foci
formation could not provide an explanation for the limitation of
RNA toxicity to a single line, (CTG)240.4.
There is no correlation between expanded RNA level
of expression and toxicity
To further investigate the molecular basis of (CUG)240.4 RNA
toxicity, RNA rates were analyzed using quantitative RT-PCR
(qRT-PCR) amplification. RNA extracted from adult heads of
GMRnina-Gal4 induced flies was reverse-transcribed using either
oligo-dT primer or random hexamers, and cDNA was amplified
using transgene-specific primers, complementary to the 39UTR of
the transcript (Figure 5A). A quantitative analysis was performed
using real time PCR amplification and the expression level of each
transgene was expressed as the ratio between (CUG)n and G-6-
PDH RNA concentrations (Figure 5B). (CUG)n expanded RNA
rates were highly variable even between lines that have the same
repeat length. The finding that also the (CUG)16 lines which do
not form nuclear foci, had an RNA rate variability within the same
range as that of the lines with larger expansions, indicates that the
RNA was quantitatively extracted from the foci. We consider that
the RNA rate accounts for the level of expression.
In conclusion, the level of expression of the (CUG)240.4 RNA
does not explain its toxicity.
(CUG)240.4 forms a fusion transcript with the RNA of
a zinc finger protein encoding gene
We then investigated whether the toxic effect of the (CUG)240.4
RNA could be accounted for by the transgene insertion context.
We assessed this hypothesis by performing inverse PCR amplifi-
cation on genomic DNA prepared from the different transgenic
lines. All but three lines had the transgene inserted in a non
transcribed region of the genome (Table 1). The (CTG)240.4 line
was one of the three exceptions. (CTG)240.4 insertion lies within
the first intron of the CG9650 gene that encodes a zinc finger
protein [20,21], in the same orientation as the endogenous
transcription unit (Figure 6A). To gain further understanding, we
investigated the expression pattern of CG9650 in the (CTG)240.4
line after induction of the transgene in the salivary glands using the
MS1096-Gal4 driver [24]. We performed RNA-FISH with CAG-
FITC and CG9650-rhodamin probes (Figure 6A). We found that
CG9650 RNA (as revealed with a probe that is complementary to
exonic sequences) was concentrated in the same nuclear foci as the
(CUG)240.4 RNA (Figure 6B). We did not observe formation of
nuclear foci when CG9650 RNA was over-expressed in a context
without any repeat expansion or when the RNA expansion was
expressed in trans from an insertion that is located at a different
locus (data not shown). Therefore, the (CUG)240.4/CG9650 foci
Figure 5. Quantitative RT-PCR amplification of (CUG)n expanded RNAs. A. Organization of the (CTG)n containing cDNAs. CTG repeat tracts (CTG)
n = 16, 240 or 480 are represented as a white box. Black boxes represent 39 and 59UTR sequences between which they were inserted (see Material and
Methods). The two PCR primers (3 and 4) used in this experiment are common to all constructs and were designed so that DNA amplification does
not cross the repeat tract. B. The bar graph represents the mean ratios of CUG expanded and G-6-PDH RNA levels as determined by quantitative RT-
PCR (qRT-PCR) amplification. Total RNA was extracted from heads of adult transgenic flies. GMRnina-Gal4 driver was used for induction in the eye.
Each of the transgenic lines used in this experiment is represented as a black bar. Abbreviations: i: induced; ni: non induced; wt: wild type.
doi:10.1371/journal.pone.0001466.g005
Table 1. Cytological and genomic mapping of the transgenic
lines’ insertions
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Transgenic
line Chromosome
Cytogenetic
map location Gene location
Relative
orientation
CTG 240.1 3 83B4 CG2922 antisense
CTG 240.2 2 53C3 intergenic
CTG 240.3 3 86B3 intergenic
CTG 240.4 1 7A2 CG9650 sense
CTG 480.1 3 67B1 intergenic
CTG 480.2 1 5F1 intergenic
CTG 480.3 1 2F1 CG3206 sense
CAG 240.1 1 3A5 intergenic
CAG 480.1 3 94A2 intergenic
CAG 480.2 2 57A7 intergenic
Genomic mapping was performed using inverse PCR amplification as indicated
in the ‘‘Material and Methods’’ section.
doi:10.1371/journal.pone.0001466.t001..
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could form only when CG9650 RNA and the CUG expansion lie
in cis within the same transcript.
On the other hand, the (CUG)240.1 and (CUG)480.3 RNAs
expressed by lines whose insertions lie also within a transcribed
region (Table 1), did not have deleterious effects. No foci
containing the endogenous RNAs were detected in these lines
(data not shown).
The formation of a fusion RNA must be an exceptional event as
a classical SV40 39UTR was used in these constructs that brings
about a functional polyadenylation signal [31]. The formation of a
fusion RNA must result from a bypass of this signal. Why this
occurred in the (CTG)240.4 line and how the fusion transcript
induced toxic effects is not clear. The important issue is that the
formation of a fusion RNA in the (CUG)240.4 line results in a
situation analogous to that observed in DM1 where the expansion
lies in the DMPK 39UTR.
DISCUSSION
Drosophila genetics has proved to be particularly powerful in
dissecting biological processes. As a result, Drosophila has been
increasingly used to model human pathologies [32,33] with the
ultimate goal of identifying genetic modifiers and eventually
finding potential new therapeutic avenues.
In the present work we wanted to generate Drosophila models to
try to understand the molecular basis of CUG expansions toxicity.
To address this complex question we generated transgenic flies
with constructs that allow expression of RNA repeats of different
type and length: (CUG)16, (CUG)240 and 480, (CAG)240 and 480.
These constructs were devoid of any of the human sequences used
in various animal or cell models for myotonic dystrophy [17,34,35]
as we wanted to concentrate our analysis exclusively on the
contribution of CUG expansions to pathogenicity.
(CUG)240 and (CUG)480 form RNA foci, most of which
are not toxic in Drosophila
In this report, we confirm that CUG expansions are sufficient to
generate ribonuclease sensitive nuclear foci provided they are long
enough. Indeed we did not observe nuclear retention of (CUG)16
containing RNAs. (CAG)240 and (CAG)480 expansions did not
form nuclear foci in spite of having a large number of repeats. The
difference in the ability of the CAG and CUG expansions to form
foci may reside in a difference in the stability of the secondary
structures that are formed by these RNAs. Other Authors have
described nuclear foci formation in cells expressing CAG
expansions [15]. The basis for this discrepancy is unclear.
Nuclear foci have been considered as a hallmark of RNA gain-
of-function toxicity. However, an increasing body of knowledge
clearly suggests that the formation of nuclear foci is not sufficient
[17,19]. Indeed, formation of foci in nuclei of various fly tissues
expressing (CUG)160 RNAs did not result in toxicity, in spite of
co-localization with the Muscleblind double stranded RNA
binding factor [18]. More recently, other Authors reported that
induction of a (CUG)480 expansion in transgenic flies recapitu-
lated at least some of the disorders associated with DM1 whereas
foci formation without toxicity was observed in (CUG)200
expressing flies [23]. It would be tempting to conclude that the
repeat length is the primary determinant of RNA expansion
toxicity in Drosophila. However, using the same vector and repeat
type [23], we did not observe toxicity upon induction of the
(CUG)480 expansions in our transgenic lines. This was true also
for all the (CUG)240 expressing lines but one, (CUG)240.4. Our
results, therefore, rule out the possibility that a specific length of
RNA repeats is the primary determinant in the gain-of-function
toxicity in fly models.
Figure 6. (CTG)240.4 expansion and CG9650 target gene expression. A. CG9650 gene organization and insertion mapping. Three CG9650 mRNAs
have been reported, form A is an EST, B and C are computationally derived. Lines represent introns and exons are represented as grey boxes. The
(CTG)240.4 transgene (green) is inserted in the first intron of CG9650 at nucleotide 2051. The position of CG9650-rhodamin probes is shown on the
diagram as red stars. B. RNA-FISH on salivary glands with CAG-FITC and CG9650-rhodamin probes (rho-CG96-1 and rho-CG96-2). Nuclei were
counterstained with DAPI. CG9650 RNA forms nuclear foci that co-localize with (CUG)240.4 RNA. MS1096-Gal4 was used for induction. No FISH staining
was detected when the transgene was not induced.
doi:10.1371/journal.pone.0001466.g006
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RNA context is the primary determinant of the CUG
expansion toxicity
The (CUG)n RNA expressing transgenes inserted randomly into
the genome, therefore the insertion context could not be
anticipated. Consequently its contribution to the RNA toxicity
could be objectively assessed. Thus we were able to show that the
only transgenic expansion that was toxic was expressed as a fusion
transcript with an endogenous RNA, a situation that is similar to
that of the RNA dominant diseases in humans. In human
pathologies, expanded RNAs result from genomic amplification of
endogenous repeats that lie within specific transcribed regions. In
DM1, the expansion lies within DMPK and in DM2, it lies within
ZNF9 [2,3,8,9].
One could argue that induction of toxicity in the fly transgenic
lines and human pathogenesis might be supported by different
mechanisms. However the trans acting factors that bind the CUG
repeats and that are reported to be implicated in DM1 [10] have
homologues in Drosophila, like CUG-BP1 [36], hnRNP H [37]
whereas the muscleblind gene was first identified in Drosophila [38].
The similarities between fly and human CUG-binding factors
point to the possibility that in DM1 pathogenesis also, the
expansion per se might not be sufficient. The expansion context or
other elements might be major determinants of the RNA toxicity
and the subsequent phenotype. Not only our findings but also
previously published work strengthen this hypothesis. In a cell
culture model large CUG expansions, in spite of their ability to
form nuclear foci, do not affect myoblast differentiation. In
contrast, myoblast differentiation is affected by the same
expansions when they are present in the DMPK 39UTR [19,39].
Another example comes from SCA8, an RNA trans dominant
neurological disease in which CUG repeat expansion was
implicated [40], here CUG expansion contribution to the
pathology is questionable with the finding that expanded repeats
are present also in healthy individuals [41]. Moreover, toxicity of
SCA8 RNA when expressed in the fly is not dependent on the
CUG repeat length [42].
The molecular basis of the RNA context contribution
to the phenotype is still elusive
The similarities that may be observed between the phenotypes that
result from expression of CUG expansions and those that result
from mis-expression of the RNA in which they reside deserve
attention. Although the phenotype of the (CTG)240.4 line cannot
be explained by a mere loss or gain of function of CG9650, both
(CUG)240.4 RNA induction (as shown in this work), and CG9650
over-expression affect the nervous system and the eye [20,21]. It is
important that no muscular disorder was induced by the
(CUG)240.4 expanded RNA analyzed in the present work.
Similarly, in the SCA8 fly models mentioned above, no muscular
disorder was induced by the CUG expansion [42].
Our hypothesis based on this work and data reported in the
literature [7] is that the trans dominant effects of the expanded
RNA may be mediated by various factors among which some must
be relevant to the pathway of the RNA in which the expansion
resides. In favour of this hypothesis is the observation that DM1
and DM2, the two neuromuscular disorders linked to repeat
expansions in DMPK and ZNF9 genes respectively, also show
significant differences [3,8]. A mouse model which presents typical
symptoms of myotonic dystrophy when a normal DMPK 39UTR
mRNA is over-expressed [17] clearly raises issues as to the relative
role of the expansion itself and of the non repeat DMPK 39UTR in
the pathogenicity of CUG expanded RNA in DM1 patients.
All these reports and the present one definitely challenge the
view of a trans dominant effect of the RNA expansion, that
depends only on the repeat type, size or level of expression.
Our hypothesis is, however, challenged by the finding that in
DM2 no ZNF9 RNA flanking sequences were found associated
with the CCUG repeats nuclear foci [43]. Although no
explanation can be provided yet, it is unlikely that the CCUG
repeat expansions, differently from the CUG tracts, have an
intrinsic toxicity.
These contradictory findings and the complexity of the RNA
dominant diseases, suggest that the molecular mechanisms of RNA
expansion toxicity are still elusive and further work is needed to
properly address this question. Drosophila models should provide an
invaluable help in solving the central question: how the mutant
RNA exerts its toxic effect. Since several laboratories are working
on the production of fly models of RNA dominant diseases, a
number of independent insertion lines should become available to
the community for a systematic investigation to be undertaken.
MATERIALS AND METHODS
Fly stocks
UASp transgenic lines were generated as described below. For germ
line transformation, experimental conditions were as described
earlier [44]. Tissue specific expression of the transgenes was achieved
by crossing these lines with various driver lines. Gal4 drivers used in
this work were MS1096-Gal4 [24], 24B-Gal4 [22], COG-Gal4 [25].
These drivers induce expression in dorsal wing disc and salivary
glands, mesoderm and ovary, respectively. Actin-Gal4 P{Act5C-
GAL4}25FO1/BL#4414, elav-Gal4, daughterless-Gal4 (Da-Gal4) and
GMRnina-Gal4 drivers were used for ubiquitous, pan-neuronal and
eye expression, respectively [26,27,29,30]. BG380-Gal4 driver was
used to induce expression in motoneurons [28].
DNA constructs
Generation of UASp/lacZ/(CTG)16 transgenic con-
structs The double stranded (CTG)16 sequence flanked by
SpeI and BglII restriction sites was obtained by hybridizing the
59ctagt(ctg)16a and 59gatct(cag)16a oligonucleotides, called (CTG)16
and anti-(CTG)16. The recipient vector was prepared as following:
Bluescript SK+ SpeI restriction site was destroyed, generating a
SK/SpeI vector. To do so, the vector was first digested with SpeI,
blunt ended with T4 DNA polymerase and religated. Eg5/
EDEN/39SV40 fragment from C06 plasmid [31] was then
inserted in this SK/SpeI vector using the EcoRI site. The EDEN
element was substituted by the (CTG)16 sequence described above
in the SK/SpeI/EDEN vector, thereby becoming the SK/SpeI/
(CTG)16 vector. The Eg5/(CTG)16/39SV40 fragment from the
SK/SpeI/(CTG)16 vector was cloned into the SK/LacZ plasmid
EcoRI site [31]. Then a NotI restriction site was inserted
downstream the SV40 39UTR sequence after ApaI/XhoI
digestion of the vector and integration of a linker generated by
hybridization of NADXAP1 (tcgaggcggccgcgggcc) and NADXAP2
(cgcggccgcc) oligonucleotides. This new LacZ/Eg5/(CTG)16/
39SV40 fragment was finally cloned into UASp [25] by using
the NotI site. The resulting UASp/lacZ/(CTG)16 construct was
used for germ line transformation.
Generation of UASp/(CTG)240 or 480 and UASp/
(CAG)240 or 480 transgenic constructs Sp72(CTG)240 and
Sp72(CTG)480 plasmids [5] were provided by T. Cooper
(Houston, Texas). (CTG)240 and 480 fragments were cut out of the
original plasmids by an XbaI/XhoI digestion, purified and cloned into
pBluescript SK+ generating SK/(CTG)240 and SK/(CTG)480
plasmids. Flanking restriction sites were added at each side of the
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repeats using XbaI-SpeI-SalI and ApaI-BglII-XhoI linker sequences.
These modifications allow the isolation of the CTG repeats as a SpeI-
BglII cartridge that can be used as above to replace the EDEN
sequence of the SK/SpeI/EDEN vector. SK/(CTG)240/39Eg5 and
SK/(CTG)480/39Eg5 plasmids were generated. The repeat
fragments were then cut out as BamHI fragments and inserted into
a BamHI-digested UASp vector, thus generating UASp/(CTG)240/
39Eg5, UASp/(CTG)480/39Eg5 and UASp/(CAG)480/39Eg5
plasmids depending on the insert orientation. These plasmid
constructs were used for germ line transformation.
The XbaI-SpeI-SalI linker was obtained by hybridizing the
XSpeIS1 (ctagactagtg) and XSpeIS2 (tcgacactagt) oligonucleotides.
The ApaI-BglII-XhoI linker was obtained by hybridizing the
XBglIIA1 (tcgagatctgggcc) and XBglIIA2 (cagatc) oligonucleotides.
To generate UASp/(CAG)240/39Eg5, a KpnI fragment was
inserted into the KpnI site of UASp vector.
The quality of the inserts was verified twice, first by sequencing the
entire fragments before their cloning into the UASp vector and then,
after the last cloning step, the sequence junctions were also verified
by sequencing (Genome Express). The expansions proved to be
highly unstable in bacteria and all these verifications were required.
The cloning procedure required to grow the bacteria at 30uC.
P element transformation was performed with the yw stock using
standard methods [44]. Three UASp/lacZ/(CTG)16, five UASp/
(CTG)240/39Eg5, three UASp/(CTG)480/39Eg5, one UASp/
(CAG)240/39Eg5, two UASp/(CAG)480/39Eg5 independent lines
were generated and were analyzed for each construct.
Genomic DNA preparation and inverse PCR
amplification
Genomic DNA (gDNA) extraction and inverse PCR amplifications
were performed following the protocol provided by the ‘‘Berkeley
Drosophila Genome Project Resources’’ (http://www.fruitfly.org).
Genomic DNA was extracted from 30 flies, isopropanol precipitated
and re-suspended in 150 ml TE as indicated in the BDGP procedure.
Genomic DNA (10 ml) was then digested either with Sau3A
(Promega) or MspI (Biolabs), re-ligated with T4 DNA ligase
(Promega) according to the manufacturer’s instructions. After
ethanol precipitation, PCR amplifications were performed ac-
cording to the protocol instructions both with Pwht1 and Plac1
primers for the 59 end and with Pry4 and Pry1 primers for the 39
end of the inserted transgene. Sequencing reactions were
performed either with Sp1 for the 59 end or with Spep1 for the
39 end using DYEnamic ET Terminator Cycle Sequencing kit and
following the manufacturer’s instructions (Amersham Biosciences).
Sequencing reactions were run on ABI PRISMTM 377 DNA
Sequencer (Applied Biosystems).
PCR reactions and gel electrophoresis analysis
For the LacZ (CTG)16 transgene, 1 ml (0.1 mg) of total DNA samples
was amplified in 50 ml reactions using GoTaqH DNA polymerase
according to the manufacturer’s instructions (Promega). For the
(CTG)240 or 480 transgenes, 1 ml (0.1 mg) of total DNA samples was
amplified in 20 ml reactions using JumpStartTM AccuTaqTM LA
DNA polymerase according to the manufacturer’s instructions
(Sigma) with 5% DMSO and 50 mM betaine. PCR amplification
reactions involved 3 cycles at 95uC (45 s), 67uC (45 s) and 72uC
(1 min 30 s) followed by 30 cycles at 95uC (45 s), 62uC (45 s) and
72uC (1 min 30 s) in a MiniCyclerTM (MJ Research). Amplified
products (5 ml) were mixed with 1 ml of loading buffer and subjected
to electrophoresis in a 1% agarose gel in 0.56TBE with ethidium
bromide and revealed by UV light. Size was determined by
comparison with a 1 kb DNA ladder (Promega).
RNA in situ hybridization (RNA-FISH) experiments
Tissue dissections Salivary glands of third instar larvae were
hand dissected in ice cold 16PBT (PBS+0.1% Tween). They were
fixed for 20 min in 4% paraformaldehyde in PBT, and then rinsed
in PBT 5 times for 15 min. They were permeabilized for 5 min in
a TE solution (10 mM Tris, 1 mM EDTA) containing 50 mg/ml
proteinase K, and then rinsed twice in a PBT solution containing
2 mg/ml of glycine and twice for 10 min in PBT. A post fixation
was performed for 20 min in 4% paraformaldehyde solution in
PBT and then rinsed in PBT 5 times for 10 min. Salivary glands
were then ready for RNA-FISH.
Muscles from third instar larvae were hand dissected. Larvae
were anesthetized by placing them for 5 min on ice. Each larva
was immerged in a drop of 16 PBS containing 10 mM EGTA,
then opened dorsally and pinned open on a siligar covered plate
with minutiens ( 0.15mm, Austerlitz insect pinsH). The cuticles
with the attached muscles were then fixed, permeabilized, after
post-fixation as indicated above they were ready for the RNA-
FISH procedure. The ovaries were hand dissected from 3 day-old
females and treated as above.
RNA-FISH method The CAG-FITC probe used was a
(CAG)6C oligonucleotide, FITC-labelled at both ends
(PROLIGO). Samples were incubated in 40% formamide, 26
SSC for 30 min and hybridized overnight at 37uC with 1 ng/ml of
the CAG-FITC probe in a 200 ml final volume of a solution
containing 40% formamide, 26 SSC, 0.2% BSA, 2 mM vanadyl
ribonucleoside complex and 1 mg/ml yeast tRNA. Samples were
then washed in 40% formamide, 26SSC for 30 min, rinsed twice
in 16 SSC in PBS for 10 min and mounted on slides with
VectashieldHDAPI-containing mounting medium (H-1200, Vector).
For double-labeling experiments with a CG9650 specific probe
(C96), 1 ng/ml of two 59 Rhodamin-labeled probes was added, rho-
C96-1 (gtagcagtgggcaattggtt) and rho-C96-2 (tcgaacagagcctcattccg).
When RNase-treated, samples were incubated for 30 min at 37uC in
a solution containing 0.1 mg/ml of a DNase and Proteinase free
ribonuclease A solution (Fermentas) prior to RNA-FISH.
Slides were examined under a Leica DMRA2 microscope;
images were captured with a photometrics coolSNAPTM HQ
camera. Images from two or three wavelengths (DAPI, FITC,
Rhodamin) were assembled and colored using Metaview Software.
RNA extraction and quantitative RT-PCR (qRT-PCR)
amplifications
RNA extraction and quantification Flies were raised at 29uC
for induction of transgene expression by GMRnina-Gal4 driver. 30
heads from 3 day-old flies were cut and immediately put in RNA
stabilizing buffer (RNAwizTM, Ambion). Total RNA was extracted
according to the manufacturer’s instructions. RNA quantification
was performed on 2 ml total RNA sample in a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE).
Quantitative RT-PCR amplification 2 mg of each of the total
RNA samples were used for first strand cDNA synthesis using
SuperscriptTM II Reverse Transcriptase (InvitrogenTM) according to
the manufacturer’s instructions. For real-time PCR amplification,
5 ng of cDNA template was used for (CUG)480 and different
dilutions were used for (CUG)240 (10, 5, 2 ng of cDNA) in a 20 ml
total reaction with 50 mM betaine, 4 mMMgCl2, 0.5 mMof primer
3 (gctgctcgagatctaagcttc) and primer 4 (aatacacttttccataactaactcg)
and 2 ml of master mix of LightCyclerH FastStart DNA Master
SYBER Green I kit (Roche Diagnostics). Transgene expression
levels were normalized to the level of G-6-PDH expression using
G-6-PDH-C2 (cgacattcgtgacgagaagg) and G-6-PDH-R1
(gttcgaatcgttgctaacgg) primers. G-6-PDH is an endogenous
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housekeeping gene [45]. The qRT-PCR experiments were
performed using a LightCycler instrument (Roche Diagnostics).
The relative expression data were treated using the Second
Derivative Maximum Method of the LightCyclerH Software 3.5
(Roche Diagnostics). qRT-PCR amplification was performed at least
four times for each of the (CUG)480 samples. For the (CUG)240 lines
and controls, four independent experiments were carried out, with
three different dilutions and two replicates for each. The mean value
and standard deviation were determined using Microsoft Excel.
Scanning Electron Microscopy (SEM)
Adult flies were frozen at280uC, coated with Gold Palladium and
examined with a Hitachi s-4000 scanning electron microscope.
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